Companies / ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc.

Nasdaq: NDRACIK 1681682ANN ARBOR, MI

Financials · FY2020

Revenue$0
Net income$-7.03M
Total debt$0
Cash$4.82M
Diluted EPS$-8.93
Shares outstanding1.3M

Ownership

1.3M shares outstanding · as of May 15, 2026
31.8%Insiders
Ownership
Insiders31.76%403,395
Institutions9.55%121,306
Public float58.69%745,376

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Anthony DiGiandomenicoDirector
10.75%136,589
Tokman Alexander YCEOChief Executive Officer · Director
8.03%101,926
Harsh MichaelDirector
5.17%65,710
Basenese LouDirector
5.17%65,709
Jacroux RichardChief Financial Officer
2.63%33,461

Institutional holders 10

View all →
HolderValue% of shares
Altium Capital Management LLC$235.1K4.09%
Citizens Financial Group INC/RI$151.4K2.24%
Geode Capital Management, LLC$98.0K1.66%
Vanguard Group Inc$58.6K1.02%
Morgan Stanley$31.5K0.55%
Northwestern Mutual Wealth Management Co$88<0.01%
UBS Group AG$54<0.01%
Bank of America Corp /De$45<0.01%
Danske Bank A/S$19<0.01%
Citigroup Inc$5<0.01%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
Citizens Financial Group INC/RI
13F manager
NewCommon Stock$151.4K+28K
28,400
2.24% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
NewCommon Stock$98.0K+21K
21,078
1.66% of shares
low
Q4 2024
as of
Danske Bank A/S
13F manager
NewCommon Stock$19+3
3
<0.01% of shares
low
Q4 2025
as of
Danske Bank A/S
13F manager
ExitCommon Stock$-19-3
-100.00%
0
low
Q4 2025
as of
Bank of America Corp /De
13F manager
AddCommon Stock$18+4
+66.67%
10
<0.01% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NDRACommon StockEquity29273B500BBG00FD4RCV3